Within its last year performance, KLRS rose by 7.87%, with highs and lows ranging from $12.90 to $2.14, whereas the simple moving average jumped by 108.15% in the last 200 days.
On November 03, 2025, Citizens JMP started tracking Kalaris Therapeutics Inc (NASDAQ: KLRS) recommending Mkt Outperform. A report published by Raymond James on September 03, 2025, Initiated its previous ‘Strong Buy’ rating for KLRS. Piper Sandler also rated KLRS shares as ‘Neutral’, setting a target price of $3 on the company’s shares in an initiating report dated July 23, 2025. Leerink Partners Initiated an Outperform rating on May 07, 2025, and assigned a price target of $20. William Blair initiated its ‘Outperform’ rating for KLRS, as published in its report on April 08, 2025.
Analysis of Kalaris Therapeutics Inc (KLRS)
In order to gain a clear picture of Kalaris Therapeutics Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -63.45% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 12.89, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 174.76K can be a very valuable indicator of volatility for KLRS stock. On a monthly basis, the volatility of the stock is set at 13.16%, whereas on a weekly basis, it is put at 15.85%, with a gain of 25.09% over the past seven days. Furthermore, long-term investors anticipate a median target price of $19.00, showing growth from the present price of $10.42, which can serve as yet another indication of whether KLRS is worth investing in or should be passed over.
How Do You Analyze Kalaris Therapeutics Inc Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 73.07%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 7.83% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
